Unknown

Dataset Information

0

Dihydropyrimidine-Thiones and Clioquinol Synergize To Target ?-Amyloid Cellular Pathologies through a Metal-Dependent Mechanism.


ABSTRACT: The lack of therapies for neurodegenerative diseases arises from our incomplete understanding of their underlying cellular toxicities and the limited number of predictive model systems. It is critical that we develop approaches to identify novel targets and lead compounds. Here, a phenotypic screen of yeast proteinopathy models identified dihydropyrimidine-thiones (DHPM-thiones) that selectively rescued the toxicity caused by ?-amyloid (A?), the peptide implicated in Alzheimer's disease. Rescue of A? toxicity by DHPM-thiones occurred through a metal-dependent mechanism of action. The bioactivity was distinct, however, from that of the 8-hydroxyquinoline clioquinol (CQ). These structurally dissimilar compounds strongly synergized at concentrations otherwise not competent to reduce toxicity. Cotreatment ameliorated A? toxicity by reducing A? levels and restoring functional vesicle trafficking. Notably, these low doses significantly reduced deleterious off-target effects caused by CQ on mitochondria at higher concentrations. Both single and combinatorial treatments also reduced death of neurons expressing A? in a nematode, indicating that DHPM-thiones target a conserved protective mechanism. Furthermore, this conserved activity suggests that expression of the A? peptide causes similar cellular pathologies from yeast to neurons. Our identification of a new cytoprotective scaffold that requires metal-binding underscores the critical role of metal phenomenology in mediating A? toxicity. Additionally, our findings demonstrate the valuable potential of synergistic compounds to enhance on-target activities, while mitigating deleterious off-target effects. The identification and prosecution of synergistic compounds could prove useful for developing AD therapeutics where combination therapies may be required to antagonize diverse pathologies.

SUBMITTER: Tardiff DF 

PROVIDER: S-EPMC5705239 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Dihydropyrimidine-Thiones and Clioquinol Synergize To Target β-Amyloid Cellular Pathologies through a Metal-Dependent Mechanism.

Tardiff Daniel F DF   Brown Lauren E LE   Yan Xiaohui X   Trilles Richard R   Jui Nathan T NT   Barrasa M Inmaculada MI   Caldwell Kim A KA   Caldwell Guy A GA   Schaus Scott E SE   Lindquist Susan S  

ACS chemical neuroscience 20170712 9


The lack of therapies for neurodegenerative diseases arises from our incomplete understanding of their underlying cellular toxicities and the limited number of predictive model systems. It is critical that we develop approaches to identify novel targets and lead compounds. Here, a phenotypic screen of yeast proteinopathy models identified dihydropyrimidine-thiones (DHPM-thiones) that selectively rescued the toxicity caused by β-amyloid (Aβ), the peptide implicated in Alzheimer's disease. Rescue  ...[more]

Similar Datasets

2017-07-18 | GSE99884 | GEO
| S-EPMC3964050 | biostudies-literature
| S-EPMC6786242 | biostudies-literature
| S-EPMC5538634 | biostudies-literature
| S-EPMC8506647 | biostudies-literature
| S-EPMC9503633 | biostudies-literature
| S-EPMC6133724 | biostudies-literature
| S-EPMC6571072 | biostudies-literature
| S-EPMC5651359 | biostudies-literature
| S-EPMC8758492 | biostudies-literature